Skip to main content
. Author manuscript; available in PMC: 2021 Jul 15.
Published in final edited form as: AIDS. 2020 Jul 15;34(9):1389–1396. doi: 10.1097/QAD.0000000000002551

Table 2.

Characteristics of 843 HIV-positive illicit drug users during 8698 study interviews stratified by noninjection substance use in the last 6 months.

Characteristics All 8698 (100%) Crack cocaine use 5226 (60%) Opioid use 983 (11%) Cocaine use 1017 (12%) Methamphetamine use 1035 (12%) Alcohol use 3953 (45%) Cannabis use 4227 (49%)
Sex (n, %) Male 5785 (67%) 3367 (64%) 658 (67%) 686 (67%) 758 (73%) 2721 (69%) 3140 (74%)
Age (years) Median (IQR) 47 (41–53) 47 (41–53) 47 (40–52) 46 (40–52) 46 (40–51) 47 (42–53) 47 (41–52)
IDU (n, %) Yes 5090 (59%) 3360 (64%) 734 (75%) 839 (82%) 716 (69%) 2388 (60%) 2624 (62%)
Substances used Median (IQR) 2 (1–3) 2 (2–3) 3 (3–4) 3 (2–4) 3 (2–4) 3 (2–3) 3 (2–3)
Homelessness (n, %) Yes 1193 (14%) 845 (16%) 199 (20%) 198 (19%) 181 (17%) 568 (14%) 633 (15%)
HIV RNA VL (log10(copies/ml)) Median (IQR) 1.6 (1.5–3.3) 1.7 (1.5–3.6) 1.7 (1.5–3.7) 1.7 (1.5–3.7) 1.5 (1.5–2.9) 1.6 (1.5–3.2) 1.6 (1.5–3.3)
CD4+ cell count (cells/μl) Median (IQR) 375 (240–547) 360 (229–523) 380 (241–566) 352 (227–500) 445 (283–623) 377 (240–548) 375 (240–550)
ART exposure (days) Median (IQR) 180 (143–180) 180 (140–180) 180 (133–180) 180 (135–180) 180 (138–180) 180 (138–180) 180 (140–180)

ART, antiretroviral therapy.